4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-043476
Chairman and CEO bought 3,800 shares at an average $1.48 ($5,641)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-06-24 | Purchase | +600 | $1.50 | $900 | 10,766,471 | D |
| Niihara Yutaka Chairman and CEO | 2021-06-25 | Purchase | +2,700 | $1.48 | $3,996 | 10,769,171 | D |
| Niihara Yutaka Chairman and CEO | 2021-06-28 | Purchase | +500 | $1.49 | $745 | 10,769,671 | D |
| Open-market purchases · 3,800 sh · avg $1.48 · $5,641 | |||||||
Loading xslF345X03/doc4.xml…